Skip to main content
TipRanks
Go Ultimate75% OFF

CytomX Therapeutics (6C1) Q4 2023 Earnings Report

0 Followers

CH:6C1 Q4 2023 EPS Results

Actual EPS
CHF 0.02
Consensus EPS
-CHF 0.04
Beat/Miss
Beat by +CHF 0.06
One Year Ago EPS
-CHF 0.35

CH:6C1 Q4 2023 Revenue Results

Actual Revenue
CHF 22.14M
Expected Revenue
CHF 16.31M
Beat/Miss
Beat by +CHF 5.83M
YoY Revenue Growth
+32.22%

Earnings Announcement Details

Quarter
Q4 2023
Date
03/11/2024
Time
After Close
Conference Call
Monday, March 11, 2024
CH:6C1 Upcoming Earnings

CytomX Therapeutics's next earnings date is estimated for February 24, 2027, based on past reporting schedules.

Q4 2023 Earnings Call Audio

CH:6C1 Q4 2023 Earnings Call
0:00 / 0:00

Q4 2023 Earnings Slide Deck

No slide deck is available for this earnings event.

Q4 2023 Earnings Call Summary

No earnings call summary is available for this earnings event.

CH:6C1 Earnings History

CH:6C1 earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Feb 24, 20272026 (Q4)-0.07--0.14――
Nov 05, 20262026 (Q3)-0.06-0.07-0.070.00% (+0.00)
Aug 06, 20262026 (Q2)-0.06-0.070―
May 07, 20262026 (Q1)-0.10-0.080.22-137.04% (-0.31)
Mar 16, 20262025 (Q4)-0.08-0.140.18-178.64% (-0.33)
Nov 06, 20252025 (Q3)-0.04-0.070.06-228.57% (-0.13)
Aug 07, 20252025 (Q2)-0.050.00-0.07100.00% (+0.07)
May 12, 20252025 (Q1)0.100.220.1458.82% (+0.08)
Mar 06, 20252024 (Q4)-0.160.180.021000.00% (+0.17)
Nov 07, 20242024 (Q3)-0.140.060.0375.00% (+0.02)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed